Literature DB >> 16982299

A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health.

Jae Kennedy1, Steve Morgan2.   

Abstract

BACKGROUND: In Canada and the United States, patients who have difficulty paying for prescribed medications are less likely to obtain them and may experience increased risks for morbidity and mortality and/or increased health care costs due to nonadherence. As prescription drug costs have risen, the ability to pay for medications has emerged as a critical public health issue.
OBJECTIVES: The objectives of this study were to estimate the rates of cost-associated nonadherence in Canada and the United States, and to identify factors that predict cost-associated nonadherence in both countries.
METHODS: This original analysis used data from the 2002/2003 Joint Canada-US Survey of Health, a household phone survey jointly conducted by Statistics Canada (Ottawa, Ontario, Canada) and the US National Center for Health Statistics (Hyattsville, Maryland). The sample included 3505 adults in Canada and 5183 adults in the United States. Weighted group comparisons and logistic regression analyses were used to identify population factors predictive of cost-associated prescription nonadherence.
RESULTS: Residents of Canada were much less likely than residents of the United States to report cost-associated nonadherence (5.1% vs 9.9%; P < 0.001). Americans without health insurance (28.2%) and Americans and Canadians without prescription-drug coverage (16.2%) were significantly more likely than those with insurance (6.2%) to report cost-associated nonadherence (P < 0.001). In addition to country of residence and insurance coverage, significant risk factors predictive of nonadherence were young age, poor health, chronic pain, and low household income.
CONCLUSIONS: The results of this analysis suggest that people with low incomes and inadequate insurance, as well as those with poor health and/or chronic symptoms, are more likely to report failing to fill a prescription due to cost. The overall rate of cost-associated nonadherence was significantly higher in the United States than in Canada, even when other person-level factors were controlled for, including health insurance and prescription-drug coverage.

Entities:  

Mesh:

Year:  2006        PMID: 16982299     DOI: 10.1016/j.clinthera.2006.07.009

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  21 in total

1.  Access to primary and preventive care among foreign-born adults in Canada and the United States.

Authors:  Lydie A Lebrun; Lisa C Dubay
Journal:  Health Serv Res       Date:  2010-09-01       Impact factor: 3.402

2.  Cost-related nonadherence to prescribed medicines among older Canadians in 2014: a cross-sectional analysis of a telephone survey.

Authors:  Augustine Lee; Steve Morgan
Journal:  CMAJ Open       Date:  2017-01-17

3.  Coping strategies used by patients infected with hepatitis C virus who are facing medication costs.

Authors:  Chiranjeev Sanyal; Ethel Langille Ingram; Ingrid S Sketris; Kevork M Peltekian; Susan Kirkland
Journal:  Can J Hosp Pharm       Date:  2011-03

4.  Potential effects of rational prescribing on national health care spending: More than half a billion dollars in annual savings.

Authors:  Jordan Littman; Roland Halil
Journal:  Can Fam Physician       Date:  2016-03       Impact factor: 3.275

5.  The effect of cost on adherence to prescription medications in Canada.

Authors:  Michael R Law; Lucy Cheng; Irfan A Dhalla; Deborah Heard; Steven G Morgan
Journal:  CMAJ       Date:  2012-01-16       Impact factor: 8.262

6.  Use of Compassionate Supply of Antiretroviral Drugs to Avoid Treatment Interruptions or Delayed Treatment Initiation among HIV-Positive Patients Living in Ontario: A Retrospective Review.

Authors:  Deborah Yoong; Mark Naccarato; Kevin Gough; Jordan Lewis; Ahmed M Bayoumi
Journal:  Healthc Policy       Date:  2015-02

7.  Adherence to therapy for Barrett's esophagus-associated neoplasia.

Authors:  Lisa Cassani; James C Slaughter; Patrick Yachimski
Journal:  United European Gastroenterol J       Date:  2015-05-05       Impact factor: 4.623

8.  Out-of-pocket prices of opioid analgesics in the United States, 1999-2004.

Authors:  Benjamin M Craig; Scott A Strassels
Journal:  Pain Med       Date:  2009-12-09       Impact factor: 3.750

9.  Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis.

Authors:  Ashra Kolhatkar; Lucy Cheng; Steven G Morgan; Laurie J Goldsmith; Irfan A Dhalla; Anne M Holbrook; Michael R Law
Journal:  CMAJ Open       Date:  2018-11-19

10.  Cost-related nonadherence to medications among patients with diabetes and chronic pain: factors beyond finances.

Authors:  Jacob E Kurlander; Eve A Kerr; Sarah Krein; Michele Heisler; John D Piette
Journal:  Diabetes Care       Date:  2009-09-03       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.